This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products.
LSB (LXU) Moves 6.1% Higher: Will This Strength Last?
by Zacks Equity Research
LSB (LXU) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Danaher (DHR) Stock Moves -1.36%: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $293.33, marking a -1.36% move from the previous day.
Danaher (DHR) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed at $287.53 in the latest trading session, marking a +0.35% move from the prior day.
Danaher (DHR) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $286.53, moving +0.17% from the previous trading session.
The Zacks Analyst Blog Highlights Comcast, Danaher, Amgen, Boeing and Canadian Pacific Railway
by Zacks Equity Research
Comcast, Danaher, Amgen, Boeing and Canadian Pacific Railway have been included in this Analyst Blog.
Top Stock Reports for Comcast, Danaher & Amgen
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Comcast Corporation (CMCSA), Danaher Corporation (DHR), and Amgen Inc. (AMGN).
Danaher (DHR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $281.40, marking a +1.25% move from the previous day.
Danaher (DHR) Stock Moves -0.5%: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $262.52, moving -0.5% from the previous trading session.
Danaher (DHR) Stock Moves -0.37%: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $263.83, moving -0.37% from the previous trading session.
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
by Zacks Equity Research
Sector ETF report for IHI
Danaher (DHR) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $272.54, moving -1.46% from the previous trading session.
4 Stocks to Gain From the Promising Diversified Operations Industry
by Avisekh Bhattacharjee
Healthy demand and improving manufacturing activities benefit players in the Zacks Diversified Operations industry. DHR, CSL, CR and GFF are stocks with strong prospects.
BRRAY vs. DHR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
BRRAY vs. DHR: Which Stock Is the Better Value Option?
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?
by Zacks Equity Research
Sector ETF report for PTH
General Electric (GE) to Restructure Steam Power Portfolio
by Zacks Equity Research
General Electric (GE) decides to reshape its steam power portfolio by divesting certain businesses to the EDF Group. It expects to record non-cash charges related to the deal.
Danaher (DHR) Tops on Q4 Earnings, Suffers From Cost Woes
by Zacks Equity Research
Danaher's (DHR) Q4 earnings reflect gains from solid segmental results and higher gross and operating margins. High costs and expenses restrict margin growth. It projects cost sales growth for 2022.
Danaher (DHR) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 7.60% and 4.38%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
5 Must-See Earnings Charts This Week
by Tracey Ryniec
These five companies have been investor favorites, but can they stay in favor this earnings season?
Griffon (GFF) Hunter Fan Buyout to Add Vigor to CPP Segment
by Zacks Equity Research
Griffon (GFF) completes the acquisition of Hunter Fan, now part of the CPP segment. The buyout is predicted to be immediately accretive to the company's earnings and cash flow.
Crane (CR) Beats Q4 Earnings Estimates, Gives Promising View
by Zacks Equity Research
Crane's (CR) Q4 earnings reflect gains from solid segmental performance and improved margin. It projects higher revenues and earnings for 2022 and announces shareholder rewards with a dividend hike.
3M's (MMM) Earnings and Revenues Surpass Estimates in Q4
by Zacks Equity Research
3M's (MMM) fourth-quarter 2021 net sales increase 0.3% year over year on account of impressive performance across its Health Care and Consumer segments.
General Electric (GE) Lags on Q4 Earnings, Gives Solid View
by Zacks Equity Research
General Electric's (GE) Q4 earnings reflect the impacts of supply shortages and poor segmental performance, except for Aviation, as well as lower costs and expenses. Earnings in 2022 are to grow y/y.
3M (MMM) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
3M (MMM) delivered earnings and revenue surprises of 13.79% and 0.08%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Conglomerates Q4 Earnings Worth a Watch This Week: GE, DHR, MMM
by Payal Jalan
Conglomerate's Q4 results are likely to reflect gains from better economic and manufacturing activities, supply-chain woes, and cost inflation. Earnings releases by GE, DHR and MMM are worth a look.
Danaher (DHR) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Danaher (DHR) Q4 results to reflect gains from better-than-expected segmental top-line performances, mainly Diagnostics and Life Sciences. Cost inflation is likely to have been affecting margins.